Harr Hematology Practice Test 2025 – 400 Free Practice Questions to Pass the Exam

Polycythemia vera is a myeloproliferative neoplasm characterized primarily by the overproduction of red blood cells, but it can also lead to elevated levels of white blood cells and platelets. This condition results in an overall increase in cell counts in the bloodstream, which is termed pancytosis.

In patients with polycythemia vera, the increased red blood cell mass leads to increased blood viscosity, and as the disease progresses, patients may also exhibit elevated white blood cell and platelet counts. Thus, the presence of an increase in all three major blood cell types—red blood cells, white blood cells, and platelets—defines pancytosis, which is characteristic of this hematological disorder.

In contrast, alternative options such as panmyelosis, which refers to increased production in all lineages of the bone marrow leading to myeloid hyperplasia but not specifically blood counts, or pancytopenia, which denotes a decrease in blood cell counts, do not align with the typical findings in polycythemia vera. Panhyperplasia, while it indicates an increase in cellularity in the bone marrow, does not specifically address the peripheral blood findings that involve elevated counts of all cell types. In essence,